Mega IgG2000 by Microbiome Labs – Dietary Supplement (120 Capsules)

Mega IgG2000 by Microbiome Labs

Mega IgG2000 is a dairy-free immunoglobulin concentrate that supports healthy digestion and maintains healthy gut barrier function. Unlike other milk-derived immunoglobulins on the market, Mega IgG2000 is derived from bovine serum, making it lactose-free, casein-free, and β-lactoglobulin-free.

What is Mega IgG2000 by Microbiome Labs?

Mega IgG2000 by Microbiome Labs is a dairy-free immunoglobulin concentrate that supports healthy digestion, binds environmental toxins, and maintains healthy gut barrier function. Unlike other milk-derived immunoglobulins on the market, Mega IgG2000 is derived from bovine serum, making it lactose-free, casein-free, and β-lactoglobulin-free.

This unique alternative to bovine colostrum supports a healthy mucosal immune system by decreasing immune activation and strengthening gut barrier function. The serum immunoglobulin in Mega IgG2000 has been the subject in over 10 published human clinical trials.

Immune Response

When an antigen enters the body, it elicits a response from the innate and adaptive branches of the immune system. The adaptive immune response utilizes B and T lymphocytes to find foreign antigens, neutralize them, and eliminate them from the body. B lymphocytes do this by producing antibodies, or immunoglobulins, that can bind to unwanted antigens and remove them from the system.

Immunoglobulin G (IgG), the most abundant antibody in the system, can be found in blood and extracellular fluid, allowing it to control infections in the body. IgG antibodies can bind a variety of pathogens, including bacteria, viruses, and fungi, as well as their toxic by-products. Binding these toxins will neutralize them and allow the immune system to safely remove them from the body.

Mega IgG2000 by Microbiome Labs how it works?

Immunoglobulin G (IgG), the most abundant antibody in the system, can be found in blood and extracellular fluid, allowing it to control infections in the body. IgG antibodies can bind a variety of pathogens, including bacteria, viruses, and fungi, as well as their toxic by-products. Binding these toxins will neutralize them and allow the immune system to safely remove them from the body.

About Microbiome Labs

The origin story of Microbiome Labs is a classic tale of forging new frontiers, complete with discovery, adversity, and a leap of faith. Neither founder set out on a path to start his own supplement company, but through persistent curiosity, Dr. Tom Bayne and Microbiologist Kiran Krishnan stumbled upon an amazing opportunity.

With a rich background in research, Kiran noticed that many supplement companies were lacking sufficient clinical data, which inspired him to design trials that were more affordable and fitting for the supplement industry. He then expanded his skill set into product development and formulation for a number of retail supplement companies. Eventually he was hired to study probiotics and discover what would become the next big probiotic in the industry: Bacillus spores.

Before Kiran discovered the spores, Dr. Tom took a step back from supplement manufacturing and settled into his own chiropractic practice. As his practice began to blossom, he found himself on the forefront of Functional Medicine, uniquely focused on his patients’ gut health. For years, probiotics had proven so ineffective and inconsistent that he eventually quit using them in his practice altogether – that is, until he saw the research that Kiran had uncovered.

With Dr. Tom’s clinical expertise and Kiran’s probiotic research, the serendipitous pair formulated the first all-spore probiotic known as MegaSporeBiotic. After a great deal of clinical validation, the team set out to launch the product in the practitioner market by attending medical conferences.

In 2014, the company exhibited at only 6 conferences and signed on a handful of new accounts. However, as the product sales began to grow, the company chose to reallocate the majority of the profits back into research, with only a minimal amount leftover for marketing. This unorthodox approach is far and away what continues to set Microbiome Labs apart from the rest of the supplement industry.

n doing so, Microbiome Labs hopes to encourage other supplement companies to follow suit, thereby raising the bar of the supplement industry as a whole. In 2018, Microbiome Labs attended over 148 conferences, initiated and/or completed 14 clinical trials, and provided key solutions to thousands of practitioners, changing over 344,000 lives… and counting.

All info sourced from Microbiome Labs: www.microbiomelabs.com

Learn more about Synergistics Europe

Learn more about Microbiome Labs

Ingredients